Zerit and Combivent drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zerit (stavudine) and Combivent (albuterol sulfate; ipratropium bromide). Common drug interactions include anhedonia among females and anorexia among males.

The phase IV clinical study analyzes what interactions people have when they take Zerit and Combivent. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Zerit?

Zerit has active ingredients of stavudine. eHealthMe is studying from 9,912 Zerit users. Check the latest studies of Zerit.

What is Combivent?

Combivent has active ingredients of albuterol sulfate; ipratropium bromide. It is often used in asthma. eHealthMe is studying from 35,341 Combivent users. Check the latest studies of Combivent.



On Aug, 04, 2026

16 people who take Zerit and Combivent together, and have interactions are studied.

Zerit and Combivent drug interactions.

What are the common drug interactions of Zerit and Combivent, by gender? *:

female:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Blood creatinine increased
  4. Decreased activity
  5. Dehydration (dryness resulting from the removal of water)
  6. Diarrhoea
  7. Dyspnoea (difficult or laboured respiration)
  8. Emotional distress
  9. Gastroenteritis (inflammation of stomach and intestine)
  10. Gastroenteritis cryptosporidial (inflammation of stomach and intestine caused by cryptosporidial infection)

male:

  1. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  2. Anxiety
  3. Pyrexia (fever)
  4. Thirst
  5. Hip arthroplasty
  6. Polydipsia (excessive thirst)
  7. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  8. Blood glucose increased
  9. Blood ph decreased
  10. Bone density decreased

What are the common drug interactions of Zerit and Combivent, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abdominal pain
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Completed suicide (act of taking one's own life)
  4. Drug abuser
  5. Drug hypersensitivity
  6. Dysarthria (speech disorder)
  7. Tongue disorder (disease of tongue)

40-49:

  1. Anxiety
  2. Hip arthroplasty
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Bone density decreased
  5. Bone loss
  6. Chronic kidney disease
  7. Confusional state
  8. Emotional distress
  9. Lethargy (tiredness)
  10. Osteopenia (a condition where bone mineral density is lower than normal)

50-59:

  1. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  2. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  3. Dysphagia (a condition in which swallowing is difficult or painful)
  4. Dyspnoea exertional (breathlessness or shortness of breath)
  5. Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
  6. Oral candidiasis (fungal infection of mouth)
  7. Pharyngolaryngeal pain
  8. Polyuria (production of too much dilute urine)
  9. Productive cough
  10. Pyrexia (fever)

60+:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Blood creatinine increased
  4. Decreased activity
  5. Emotional distress
  6. Impaired work ability
  7. Osteopenia (a condition where bone mineral density is lower than normal)
  8. Osteoporosis (bones weak and more likely to break)
  9. Pain
  10. Quality of life decreased

What are the existing conditions these people have? *

  1. Hiv Infection: 9 people, 56.25%
  2. Depression: 5 people, 31.25%
  3. Stress And Anxiety: 4 people, 25.00%
  4. High Blood Pressure: 4 people, 25.00%
  5. Pneumonia: 2 people, 12.50%
  6. Peripheral Neuropathy (damage to nerves of the peripheral nervous system): 2 people, 12.50%
  7. Pain: 2 people, 12.50%
  8. Oral Candidiasis (fungal infection of mouth): 2 people, 12.50%
  9. Insomnia (sleeplessness): 2 people, 12.50%
  10. Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Zerit and Combivent?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zerit and Combivent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zerit:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Combivent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zerit and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Combivent and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on stavudine and albuterol sulfate; ipratropium bromide (the active ingredients of Zerit and Combivent, respectively), and Zerit and Combivent (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: